LAURIE NAFF: Open Payments
NPI 1225502503 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,690 in 182 payments from 33 companies in 2025. Trend: 2023 $182 · 2024 $124 · 2025 $4,690
Food & beverage: $4,690
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $628 |
| Amgen Inc. | 21 | $487 |
| Dexcom, Inc. | 10 | $482 |
| Radius Health, Inc. | 11 | $435 |
| Insulet Corporation | 10 | $347 |
| Mannkind Corporation | 12 | $328 |
| Sequel Med Tech, LLC | 7 | $279 |
| Tandem Diabetes Care, Inc. | 9 | $190 |
| Corcept Therapeutics | 7 | $173 |
| Medtronic, Inc. | 7 | $135 |
Products named: Dexcom G6 Transmitter, Tymlos, Wegovy, Omnipod, AFREZZA, TWIIST, EVENITY, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across VA — which companies pay providers there.
